194 related articles for article (PubMed ID: 38126211)
1. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
3. Defective Flow-Migration Coupling Causes Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
Park H; Furtado J; Poulet M; Chung M; Yun S; Lee S; Sessa WC; Franco CA; Schwartz MA; Eichmann A
Circulation; 2021 Sep; 144(10):805-822. PubMed ID: 34182767
[TBL] [Abstract][Full Text] [Related]
4. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
[TBL] [Abstract][Full Text] [Related]
5. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
[TBL] [Abstract][Full Text] [Related]
6. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
[TBL] [Abstract][Full Text] [Related]
7. CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia.
Dinakaran S; Zhao H; Tang Y; Wang Z; Ruiz S; Nomura-Kitabayashi A; Blanc L; Faughnan ME; Marambaud P
bioRxiv; 2023 Sep; ():. PubMed ID: 37745444
[TBL] [Abstract][Full Text] [Related]
8. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations.
Balachandar S; Graves TJ; Shimonty A; Kerr K; Kilner J; Xiao S; Slade R; Sroya M; Alikian M; Curetean E; Thomas E; McConnell VPM; McKee S; Boardman-Pretty F; Devereau A; Fowler TA; Caulfield MJ; Alton EW; Ferguson T; Redhead J; McKnight AJ; Thomas GA; ; Aldred MA; Shovlin CL
Am J Med Genet A; 2022 Mar; 188(3):959-964. PubMed ID: 34904380
[TBL] [Abstract][Full Text] [Related]
10. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
[TBL] [Abstract][Full Text] [Related]
12. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
[TBL] [Abstract][Full Text] [Related]
13. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
[TBL] [Abstract][Full Text] [Related]
14. ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver.
Schmid CD; Olsavszky V; Reinhart M; Weyer V; Trogisch FA; Sticht C; Winkler M; Kürschner SW; Hoffmann J; Ola R; Staniczek T; Heineke J; Straub BK; Mittler J; Schledzewski K; Ten Dijke P; Richter K; Dooley S; Géraud C; Goerdt S; Koch PS
Hepatology; 2023 Apr; 77(4):1211-1227. PubMed ID: 35776660
[TBL] [Abstract][Full Text] [Related]
15. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.
Han C; Choe SW; Kim YH; Acharya AP; Keselowsky BG; Sorg BS; Lee YJ; Oh SP
Angiogenesis; 2014 Oct; 17(4):823-830. PubMed ID: 24957885
[TBL] [Abstract][Full Text] [Related]
16. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
Snodgrass RO; Chico TJA; Arthur HM
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
[TBL] [Abstract][Full Text] [Related]
17. SMAD4 maintains the fluid shear stress set point to protect against arterial-venous malformations.
Banerjee K; Lin Y; Gahn J; Cordero J; Gupta P; Mohamed I; Graupera M; Dobreva G; Schwartz MA; Ola R
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37490341
[TBL] [Abstract][Full Text] [Related]
18. Localized conditional induction of brain arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
Scherschinski L; Han C; Kim YH; Winkler EA; Catapano JS; Schriber TD; Vajkoczy P; Lawton MT; Oh SP
Angiogenesis; 2023 Nov; 26(4):493-503. PubMed ID: 37219736
[TBL] [Abstract][Full Text] [Related]
19. Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.
Kim YH; Kim MJ; Choe SW; Sprecher D; Lee YJ; P Oh S
J Thromb Haemost; 2017 Jun; 15(6):1095-1102. PubMed ID: 28339142
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
Brinjikji W; Iyer VN; Wood CP; Lanzino G
J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]